InnovationRx: Positive Clinical Trial Results For Generative AI-Designed Drug

By Forbes | Nov 13, 2024 at 07:51 PM EST

Insilico Medicine's AI-designed drug shows promise in treating pulmonary fibrosis. Enveda's AI-driven approach targets dermatitis. FDA approvals, partnerships, and investments in healthcare innovation are on the rise. Research on GLP-1 drugs' effects on alcohol use disorder yields promising results.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.